Literature DB >> 11254557

Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture.

S Yang1, R Tamai, S Akashi, O Takeuchi, S Akira, S Sugawara, H Takada.   

Abstract

An analog of 1alpha,25-dihydroxyvitamin D3, 22-oxyacalcitriol (OCT), differentiated human monocytic THP-1 and U937 cells to express membrane CD14 and rendered the cells responsive to bacterial cell surface components. Both THP-1 and U937 cells expressed Toll-like receptor 4 (TLR4) on the cell surface and TLR4 mRNA in the cells, irrespective of OCT treatment. In contrast, OCT-treated U937 cells scarcely expressed TLR2 mRNA, while OCT-treated THP-1 cells expressed this transcript. Muramyldipeptide (MDP) by itself exhibited only a weak ability to induce secretion of inflammatory cytokines such as interleukin-8 (IL-8) in the OCT-differentiated THP-1 cells but showed marked synergistic effects with Salmonella lipopolysaccharide (LPS) or lipoteichoic acid (LTA) from Staphylococcus aureus, both of which exhibited strong activities. Combinatory stimulation with LPS plus LTA did not show a synergistic effect on OCT-differentiated THP-1 cells. Similar results were observed in OCT-differentiated U937 cells, although combination experiments were carried out only with MDP plus LPS. Anti-CD14 monoclonal antibody (MAb) MY4, anti-TLR4 MAb HTA125, and the synthetic lipid A precursor LA-14-PP almost completely inhibited the IL-8-inducing activities of LTA as well as LPS on OCT-treated THP-1 cells, but these treatments increased MDP activity. OCT-treated THP-1 cells primed with MDP exhibited enhanced production of IL-8 upon stimulation with LPS, while the cells primed with LPS showed no change in production upon stimulation with MDP. MDP up-regulated mRNA expression of an adapter molecule to TLRs, MyD88, to an extent similar to that for LPS in OCT-treated THP-1 cells. These findings suggested that LTA as well as LPS activated human monocytic cells in a CD14- and TLR4-dependent manner, whereas MDP exhibited activity in a CD14-, TLR4-, and probably TLR2-independent manner and exhibited synergistic and priming effects on the cells for cytokine production in response to various bacterial components.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254557      PMCID: PMC98129          DOI: 10.1128/IAI.69.4.2045-2053.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

Review 1.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

2.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

3.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.

Authors:  A Yoshimura; E Lien; R R Ingalls; E Tuomanen; R Dziarski; D Golenbock
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

Review 4.  The biology of Toll-like receptors.

Authors:  T K Means; D T Golenbock; M J Fenton
Journal:  Cytokine Growth Factor Rev       Date:  2000-09       Impact factor: 7.638

5.  Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide).

Authors:  E E Ribi; J L Cantrell; K B Von Eschen; S M Schwartzman
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

6.  Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal).

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Zentralbl Bakteriol Orig A       Date:  1979-04

7.  Endotoxin-induced antitumor activity in the mouse is highly potentiated by muramyl dipeptide.

Authors:  N Bloksma; F M Hofhuis; J M Willers
Journal:  Cancer Lett       Date:  1984-06       Impact factor: 8.679

8.  Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treated mice.

Authors:  H Takada; C Galanos
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

9.  Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release.

Authors:  D H Silverman; H Wu; M L Karnovsky
Journal:  Biochem Biophys Res Commun       Date:  1985-09-30       Impact factor: 3.575

10.  Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.

Authors:  L A Chedid; M A Parant; F M Audibert; G J Riveau; F J Parant; E Lederer; J P Choay; P L Lefrancier
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

View more
  52 in total

1.  NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.

Authors:  Anne Månsson Kvarnhammar; Terese Petterson; Lars-Olaf Cardell
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling.

Authors:  Md A Nahid; Minoru Satoh; Edward K L Chan
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

3.  Monocytic cell activation by Nonendotoxic glycoprotein from Prevotella intermedia ATCC 25611 is mediated by toll-like receptor 2.

Authors:  S Sugawara; S Yang; K Iki; J Hatakeyama; R Tamai; O Takeuchi; S Akashi; T Espevik; S Akira; H Takada
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 4.  NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease.

Authors:  T Watanabe; A Kitani; W Strober
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

5.  Induction of Nod1 and Nod2 intracellular pattern recognition receptors in murine osteoblasts following bacterial challenge.

Authors:  Ian Marriott; Dana M Rati; Samuel H McCall; Susanne L Tranguch
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 6.  The role of Toll-like receptors in CNS response to microbial challenge.

Authors:  Gregory W Konat; Tammy Kielian; Ian Marriott
Journal:  J Neurochem       Date:  2006-08-08       Impact factor: 5.372

Review 7.  The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.

Authors:  Ivan Tattoli; Leonardo H Travassos; Leticia A Carneiro; Joao G Magalhaes; Stephen E Girardin
Journal:  Semin Immunopathol       Date:  2007-08-10       Impact factor: 9.623

8.  NOD1 expression in the eye and functional contribution to IL-1beta-dependent ocular inflammation in mice.

Authors:  Holly L Rosenzweig; Kellen T Galster; Stephen R Planck; James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-13       Impact factor: 4.799

9.  Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway.

Authors:  Susu M Zughaier; Yih-Ling Tzeng; Shanta M Zimmer; Anup Datta; Russell W Carlson; David S Stephens
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  The expression and function of Nod-like receptors in neutrophils.

Authors:  Anna-Karin Ekman; Lars Olaf Cardell
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.